Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) EBIT Margin: 2018-2021

  • Genmab A's EBIT Margin fell 6278.00% to 0.00% in Q2 2021 from the same period last year, while for Jun 2021 it was 0.00%, marking a year-over-year decrease of 1252.00%. This contributed to the annual value of 62.44% for FY2020, which is 1328.00% up from last year.
  • According to the latest figures from Q2 2021, Genmab A's EBIT Margin is 0.00%, which was up 100.00% from -2.84% recorded in Q4 2020.
  • Genmab A's EBIT Margin's 5-year high stood at 66.44% during Q4 2019, with a 5-year trough of -26.63% in Q2 2019.
  • Over the past 3 years, Genmab A's median EBIT Margin value was 0.00% (recorded in 2021), while the average stood at 19.95%.
  • The largest annual percentage gain for Genmab A's EBIT Margin in the last 5 years was 8,941bps (2020), contrasted with its biggest fall of 6,928bps (2020).
  • Quarterly analysis of 4 years shows Genmab A's EBIT Margin stood at 38.52% in 2018, then surged by 2,792bps to 66.44% in 2019, then crashed by 6,928bps to -2.84% in 2020, then tumbled by 6,278bps to 0.00% in 2021.
  • Its EBIT Margin stands at 0.00% for Q2 2021, versus -2.84% for Q4 2020 and 62.78% for Q2 2020.